Benitec, Commonwealth Scientific and Industrial Research Organization deal

Benitec and CSIRO terminated their 2003 Capital Growth Agreement and Commercial Agreement for IP related to DNA-directed RNAi (ddRNAi) gene silencing technology. In exchange, CSIRO will receive a 10% ...